Showing results (91-100 of 434) with videos related to
Sort By:
Pageof 44
Therapeutic Advances in Medical Oncology|December 12, 2024
Enhancing efficacy of the MEK inhibitor trametinib with paclitaxel in KRAS-mutated colorectal cancerSusmita Ghosh, Fan Fan, Reid Powell, et al.Investigational New Drugs|November 4, 2022
Phase 1 study of the safety, pharmacokinetics, and preliminary efficacy of CA102N as monotherapy and in combination with trifluridine-tipiracil in patients with locally advanced or metastatic solid tumorsShubham Pant, Tomislav Dragovich, Christopher Lieu, et al.Cancer Treatment Reviews|July 30, 2015
Extended RAS analysis for anti-epidermal growth factor therapy in patients with metastatic colorectal cancerJ Randolph Hecht, Jean-Yves Douillard, Lee Schwartzberg, et al.Anticancer Research|April 22, 2011
Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancerDavid R Fogelman, Robert A Wolff, Scott Kopetz, et al.Cancers|November 27, 2021
Identification of Gene Co-Expression Networks Associated with Consensus Molecular Subtype-1 of Colorectal CancerSha'Kayla K Nunez, Corey D Young, Ti'ara L Griffen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Systematic survey of therapeutic trials for metastatic colorectal cancer: room for improvement in the critical pathwayScott Kopetz, Michael Overman, David Z Chang, et al.The Journal of Molecular Diagnostics : JMD|August 12, 2019
Development and Application of Duplex Sequencing Strategy for Cell-Free DNA-Based Longitudinal Monitoring of Stage IV Colorectal CancerSaradhi Mallampati, Stephanie Zalles, Dzifa Y Duose, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 6, 2016
Predictors of health-related quality of life and association with survival may identify colorectal cancer patients at high risk of poor prognosisMonica E Reyes, Yuanqing Ye, Yeling Zhou, et al.Journal of Pharmacokinetics and Pharmacodynamics|November 4, 2019
Population pharmacokinetics and covariate analysis of Sym004, an antibody mixture against the epidermal growth factor receptor, in subjects with metastatic colorectal cancer and other solid tumorsLene Alifrangis, Rik Schoemaker, Niels J Skartved, et al.Molecular Cancer Therapeutics|September 10, 2011
Combining curcumin (diferuloylmethane) and heat shock protein inhibition for neurofibromatosis 2 treatment: analysis of response and resistance pathwaysLaura S Angelo, Ji Yuan Wu, Feng Meng, et al.Pageof 44